Honasa buys 58% of Fluence Pharma for Rs 135 Cr, launches Honasa Health for D2C wellness play
Mamaearth parent enters the Rs 16,000 Cr nutraceuticals market via Fluence Pharma, acquiring 58% at Rs 135 Cr EV with the remaining 42% over 5-7 years. Fluence brings 3,000+ dermatologist relationships, hair/skin supplement brands (Hair Fact, Skin Fact), Rs 40 Cr FY26 revenue and 20%+ EBITDA margins.
Honasa Consumer acquires 58% of nutraceuticals firm Fluence Pharma at Rs 135 Cr EV, with remaining 42% over 5-7 years. Forms Honasa Health subsidiary to enter D2C science-led wellness, leveraging Fluence's dermatologist network and hair/skin supplement brands.
Also reported by
- Entrackr · Newsletter — Same time